Figure 1.
KLF9 is upregulated in DCM: The protein (A) and mRNA (B) levels of KLF9 in the hearts of 2-, 3-, and 4-month-old mice after the final STZ injection (n = 6). The protein (C) and mRNA (D) levels of KLF9 at 12, 24, and 48 h in cardiomyocytes exposed to high glucose (HG) (n = 6). * p < 0.05 vs. the CON group.
